Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.
Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.
批准号:
11670563
负责人:
SAIJO Yasuo
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
白细胞介素-1 β(IL-1β)是一种多功能的促炎细胞因子,几乎影响所有细胞类型。本研究构建了信号肽与人IL-1β基因杂交的逆转录病毒表达载体。用IL-1β基因转导小鼠刘易斯肺癌(LLC)细胞(LLC/IL-1β)。LLC/IL-1β促进小鼠肿瘤生长,但对肿瘤生长特性无明显影响。LLC/IL-1β肿瘤中CD 31的免疫组化显示过度新生血管形成。LLC/IL-1β细胞分泌大量VEGF和MIP-2,其主要功能之一是血管生成。此外,LLC/IL-1β肿瘤含有超过4倍浓度的肝细胞生长因子(HGF),尽管LLC/IL-1β细胞本身在体外不分泌HGF。原位杂交结果显示,间质成纤维细胞高表达HGF mRNA,抗血管生成剂TNP-470可抑制LLC/IL-1β细胞的肿瘤生长。这些结果表明,分泌IL-1β到肿瘤环境中诱导来自癌症和基质细胞的几种血管生成因子,从而通过新血管形成促进肿瘤生长。
英文摘要
Interleukin-1β (IL-1β) is a multifunctional and proinflamatory cytokine and affects nearly all cell type. In this study, we have constructed the retroviral vector expressing a hybrid gene of signal sequence and human IL-1β gene. Mouse Lewis lung carcinoma (LLC) cells were transduced with IL=1β gene (LLC/IL-1β). LLC/IL-1β accelerated tumor growth in mice despite of no change of growth property in vitro. Immunohistochemistry of CD31 in LLC/IL-1β tumor revealed hyper-neovascularization. LLC/IL-1β cells secreted larger amount of VEGF and MIP-2 whose one of main function is angigenesis. Moreover, LLC/IL-1β tumor contained over 4 times higher concentration of hepatocyte growth factor (HGF), although LLC/IL-1β cells itself did not secreted HGF in vitro. In situ hybridization of HGF mRNA demonstrated that stromal fibroblasts overexpressed HGF mRNA.An anti-angiogenic agent TNP-470 inhibited tumor growth of LLC/IL-1β cells. These results demonstrated that secreting IL-1β into tumor milieu induces several angiogenic factors from cancer and stromal cells and thus promotes tumor growth through neovascularization.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Masashi Tanaka, Yasuo Saijo, George Sato, Takuji Suzuki, Ryushi Tazawa, Ken Satoh, and Toshihiro Nukiwa.: "Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in Low Antigenic Lewis Lung Carcinoma."Cancer Gene Therapy. 7. 1
Masashi Tanaka、Yasuo Saijo、George Sato、Takuji Suzuki、Ryushi Tazawa、Ken Satoh 和 Toshihiro Nukiwa。:“在低抗原性路易斯肺癌中使用 IL-2 和 IL-12 联合免疫基因疗法诱导抗肿瘤免疫。”癌症基因
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka M,Narumi K,Isemura M,Abe M,Sato M,Saijo Y et al.: "Expression of the 37-kda laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis."Cancer Letters. 153. 161-167 (2000)
Tanaka M、Narumi K、Isemura M、Abe M、Sato M、Saijo Y 等人:“鼠肺肿瘤细胞中 37-kda 层粘连蛋白的表达与肿瘤血管生成相关。”《癌症快报》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saijo Y.et al.: "Autologous high killing cytotoxic T lymphocytes against human lung cancer are induced using IL-1β, IL-2, IL-4, and IL-6"Clinical Cancer Research. 5. 1203-1209 (1999)
Saijo Y.等人:“使用IL-1β、IL-2、IL-4和IL-6诱导针对人肺癌的自体高杀伤性细胞毒性T淋巴细胞”临床癌症研究5. 1203-1209 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka M,Saijo Y,Sato G,Suzuki T,Tazawa R,Satoh K,Nukiwa T.: "Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic lewis lung carcinoma."Cancer Gene Therapy. 7. 1481-1490 (2000)
Tanaka M、Saijo Y、Sato G、Suzuki T、Tazawa R、Satoh K、Nukiwa T.:“在低抗原性刘易斯肺癌中使用 IL-2 和 IL-12 联合免疫基因治疗诱导抗肿瘤免疫。”癌症基因治疗
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takuji Suzuki, Yasuo Saijo, Masahito Ebina, Masahiro Yaekashiwa, Masayoshi Minegishi, Shigeru Tsuchiya, Tasuke Konno, Shuichi Ono, Yuji Matsumura, Shigefumi Fujimura, and Toshihiro Nukiwa: "Bilateral pneumothoraces with multiple bullae in a patient with b
Takuji Suzuki、Yasuo Saijo、Masahito Ebina、Maesahiro Yaekashiwa、Masayoshi Minegishi、Shigeru Tsuchiya、Tasuke Konno、Shuichi Ono、Yuji Matsumura、Shigefumi Fujimura 和 Toshihiro Nukiwa:“双侧气胸伴多发大疱的患者
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
a study and new treatment of lung cancer stem cells
-
批准号:20390229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2008
-
负责人:SAIJO Yasuo
-
依托单位:
Tumor-Targeting gene therapy and regeneration of injured lung by mssenchymal stem cells
-
批准号:16390232
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2004
-
负责人:SAIJO Yasuo
-
依托单位:
Immuno-gene therapy for non-small lecclung cancer using innate immunity by NKG2D and its ligand.
-
批准号:13670588
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:SAIJO Yasuo
-
依托单位: